Xiaole Shen
About Xiaole Shen
Xiaole Shen is a Senior Principal Scientist at Bristol Myers Squibb with extensive experience in pharmaceutical formulation development and regulatory filing.
Current Role at Bristol Myers Squibb
Xiaole Shen serves as a Senior Principal Scientist at Bristol Myers Squibb, located in Summit, New Jersey, United States. His responsibilities in this role leverage his extensive background in pharmaceutical formulation development and project management. Shen's expertise in both oral and injectable dosage forms contributes significantly to the organization's goals, particularly in regulatory filing and compliance.
Past Leadership Role at Sino-American Pharmaceutical Professionals Association
Between 2017 and 2020, Xiaole Shen held the position of President at the Sino-American Pharmaceutical Professionals Association (SAPPA) in New Jersey. During his three-year tenure, he guided the organization's initiatives in representing pharmaceutical professionals, fostering industry connections, and promoting professional development within the community.
Experience at Celgene
From 2009 to 2020, Xiaole Shen worked as a Principal Scientist at Celgene. Overhis 11-year tenure, Shen contributed to numerous projects, honing his skills in pharmaceutical formulation development. His role involved project management and regulatory filings, ensuring the successful path of multiple pharmaceutical products through the approval process.
Research Scientist Role at Wyeth
Xiaole Shen held the position of Sr. Research Scientist II at Wyeth from 2002 to 2009. During his seven-year period with the company, Shen worked extensively on analytical and physical chemistry projects. His contributions in formulation development during this time provided a strong foundation for his later roles in the pharmaceutical industry.
Educational Background in Chemistry
Xiaole Shen obtained his Ph.D. in Analytical Chemistry from The Graduate Center, City University of New York. He also holds a Bachelor of Science degree in Physical Chemistry from Fudan University. His robust academic grounding in both analytical and physical chemistry underpins his extensive expertise in pharmaceutical formulation development and regulatory compliance.